Literature DB >> 7964485

The structure of an alternate form of complement C3 that displays costimulatory growth factor activity for B lymphocytes.

Y Cahen-Kramer1, I L Mårtensson, F Melchers.   

Abstract

In this study, the structure of a novel 1.9-kb transcript coding for complement component 3 (C3) is described. This alternate C3 is identical to the 3' end of the C3 message beginning at position 3300 of the C3 cDNA. Its transcription appears to be driven by an alternate promoter located within intron 8 of the C3 gene. This alternate C3 message contains an open reading frame that may encode a 536-amino acid-long protein identical to the 3' part of the C3 alpha chain. The resulting protein contains the complement receptor CR2 binding site. The suggested 5' end of coding region of the alternate C3 includes information for a potential hydrophobic leader peptide that would allow secretion of the protein. In vitro assays with macrophage-depleted mouse splenic B cells indicate that an activity is secreted from cell lines transfected with the alternate C3 cDNA. Together with Sepharose-bound immunoglobulin M-specific monoclonal antibodies and interleukin 2, it costimulates the proliferation of B cells. Implications for possible in vivo functions are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964485      PMCID: PMC2191791          DOI: 10.1084/jem.180.6.2079

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  49 in total

1.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

Authors:  J F Kearney; A Radbruch; B Liesegang; K Rajewsky
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  Complement dependence of localisation of aggregated IgG in germinal centres.

Authors:  M Papamichail; C Gutierrez; P Embling; P Johnson; E J Holborow; M B Pepys
Journal:  Scand J Immunol       Date:  1975       Impact factor: 3.487

3.  Variability in the lambda light chain sequences of mouse antibody.

Authors:  M G Weigert; I M Cesari; S J Yonkovich; M Cohn
Journal:  Nature       Date:  1970-12-12       Impact factor: 49.962

Review 4.  Organization and expression of eucaryotic split genes coding for proteins.

Authors:  R Breathnach; P Chambon
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

5.  Purification and partial characterization of the third component of the complement system from porcine serum (C3) and of a crystallizable degradation product of the fourth component of the complement system from human serum (C4). Study of the tryptic digestion products of human and porcine C3 and of human C4.

Authors:  E P Pâques
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1980

6.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

7.  Studies on immunosuppression by cobra venom factor. II. On responses to DNP-Ficoll and DNP-Polyacrylamide.

Authors:  T Matsuda; G P Martinelli; A G Osler
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

8.  T-cell hybridomas which produce B lymphocyte replication factors only.

Authors:  W Lernhardt; C Corbel; R Wall; F Melchers
Journal:  Nature       Date:  1982-11-25       Impact factor: 49.962

9.  Complement factors H and I synthesized by B cell lines function to generate a growth factor activity from C3.

Authors:  V Vĕtvicka; W Reed; M L Hoover; G D Ross
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

10.  Murine complement component 3: genetic variation and linkage to H-2.

Authors:  F P Da Silva; G F Hoecker; N K Day; K Vienne; P Rubinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

View more
  2 in total

1.  Interaction of Serum-Derived and Internalized C3 With DNA in Human B Cells-A Potential Involvement in Regulation of Gene Transcription.

Authors:  Mariann Kremlitzka; Alicja A Nowacka; Frida C Mohlin; Pradeep Bompada; Yang De Marinis; Anna M Blom
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

2.  Interleukin 6 influences germinal center development and antibody production via a contribution of C3 complement component.

Authors:  M Kopf; S Herren; M V Wiles; M B Pepys; M H Kosco-Vilbois
Journal:  J Exp Med       Date:  1998-11-16       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.